Nektar Therapeutics | NKTR - Ordinary Share Capital


Nektar Therapeutics reported $19K in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
ALKERMES USD 165.61M 503K Dec/2025
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Amgen USD 539M 1000K Dec/2025
Baxter International USD 514.28M 168.72M Dec/2025
BioCryst Pharmaceuticals USD 1.9M 3K Sep/2023
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 2K 3K Mar/2025
Cipla INR 807.77M 807.43M Sep/2025
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 112K 11K Sep/2023
Exelixis USD 268.1M 2.03M Sep/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Grifols EUR 679.73M 0 Sep/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 13K 0 Sep/2024
MacroGenics USD 63.26M 62.63M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Xencor USD 71.87M 529K Dec/2025